What is the Prognosis for Patients with FGFR2 Mutations?
The prognosis for patients with FGFR2 mutations varies depending on several factors, including the type of cancer, the specific mutation, and the stage of the disease at diagnosis. Generally, the presence of FGFR2 mutations can indicate a more aggressive form of cancer. However, the advent of targeted therapies has improved outcomes for many patients. Ongoing research and clinical trials continue to explore new treatment options and improve prognoses for those affected by these mutations.
